The old man smells badly and guards against Parkinson’s disease

The old man smells badly and guards against Parkinson’s disease

Parkinson’s disease is called the “third killer” of middle-aged and elderly people, and it is second only to tumors, cardiovascular and cerebrovascular diseases.

  ”In many people’s minds, ‘shake’ is a typical symptom of Parkinson’s. In fact, there are many signals that mean that Parkinson may be affected.

Professor Chen Wei, deputy head of the Parkinson’s Disease and Movement Disorders Group of the Chinese Medical Association’s Neurology Branch, said that sudden loss of smell, sleep disorders, nightmares, kicking quilts, constipation, depression, etc. should be timely.Go to the neurology department to find a specialist.

  Sudden loss of sense of smell, careful Parkinson, especially the sense of smell, nearly half of patients with Parkinson’s disease have experienced olfactory loss in the early stage, but often easily overlooked.

Once found, the diagnosis should be made early by means of olfactory examination and imaging examination.

  In addition, dyskinesia remains a unique manifestation of early Parkinson’s patients.

Some old people have slowed their upper limbs, buckled their clothes, and slowed their shoelaces, but none of them suffered from Parkinson.

Clinically, some people who have suffered brain trauma, gas poisoning, pesticide poisoning, heavy metal poisoning, and family history are most susceptible to this disease.

  “There are currently about 2 million patients with Parkinson’s disease in mainland China, but the diagnosis and treatment are still not standardized, and almost half of the patients are not treated.

Professor Chen Shengdi, head of the Parkinson’s Disease and Movement Disorders Group of the Chinese Medical Association’s Neurology Branch, pointed out that most clinicians are not well aware of the disease and the medication is not standardized, which makes patients miss the opportunity of early treatment.

  In order to standardize the treatment level, the Chinese Medical Association Neurology Branch jointly launched the “Chinese Parkinson’s Disease Guide Miles” neurology physicians continuing education this year with Boehringer Ingelheim.

Chen Shengdi revealed that the new treatment guidelines recommend non-ergot-type dopamine agonists as the first choice for early treatment, meaning that the concept of Parkinson’s disease treatment in China has been in line with international standards.